Browse 24839 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
December 11th, 2023 |
Sustaining Impact for Youth Activity |
Haiti USAID Port Au Prince |
February 21st, 2024 |
Building an Effective, Robust and Sustainable Integrated Sample Transportation System in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
December 28th, 2023 |
Fortifying OVC services, Empowering adolescents, and youth, and Leveraging and Incorporating community feedback in Zambezia (FELIZ) Activity |
Mozambique USAID Maputo |
April 16th, 2024 |
Resource Center for Cannabis and Cannabinoid Research (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
February 1st, 2024 |
Fiscal Year (FY) 2024 AmeriCorps Seniors Senior Companion Program (SCP) Replacement and Expansion Opportunity |
AmeriCorps |
February 1st, 2024 |
Fiscal Year (FY 2024 AmeriCorps Seniors Foster Grandparents (FGP) Replacement and Expansion Opportunity Program |
AmeriCorps |
March 14th, 2024 |
Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional) |
National Institutes of Health |
March 14th, 2024 |
Tools for Decentralized Clinical Trials for Substance Use Disorder (R41/R42 Clinical Trials Optional) |
National Institutes of Health |
May 7th, 2024 |
Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R01-Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2024 |
Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R21-Clinical Trial Not Allowed) |
National Institutes of Health |
March 13th, 2024 |
Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
March 13th, 2024 |
Long-Acting Drug Delivery Systems for ART Optimization in Children Living with HIV-1 II (LADDS II) (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
January 26th, 2024 |
Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 28th, 2024 |
Single Source for continuation of the Human Pancreas Analysis Program for Type-2 Diabetes (HPAP-T2D) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
April 15th, 2024 |
Early Detection of Certain Medical Conditions Related to Environmental Health Hazards |
Centers for Disease Control ATSDR |
April 15th, 2024 |
State Biomonitoring Programs: Assessing disproportionate exposure to environmental chemicals among communities |
Centers for Disease Control NCEH |
March 8th, 2024 |
Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Pathogens in China |
Centers for Disease Control and Prevention ERA |
November 29th, 2023 |
Special Diabetes Program for Indians, Community Directed |
Indian Health Service |
November 28th, 2023 |
ARPA-H Biomedical Data Fabric Toolbox |
Advanced Research Projects Agency for Health |
January 26th, 2024 |
Down Syndrome Clinical Cohort Coordinating Center (DS-4C) for the INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
|
December 15th, 2023 |
Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
December 15th, 2023 |
Down Syndrome Cohort Research Sites (DS-CRS) for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2028 |
NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) |
National Institutes of Health |
October 27th, 2026 |
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) |
National Institutes of Health |
October 13th, 2025 |
RFA-OE-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-OT-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-CD-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-CC-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-TP-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-EH-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-CE-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-DP-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-CK-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-IP-18-000 |
Centers for Disease Control and Prevention ERA |
February 20th, 2024 |
Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required) |
National Institutes of Health |
October 13th, 2025 |
RFA-PS-18-000 |
Centers for Disease Control and Prevention ERA |
January 7th, 2027 |
Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional) |
National Institutes of Health |
November 19th, 2024 |
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
December 19th, 2023 |
HEAL Initiative: Limited Competition: Clinical Centers for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (UG1 Clinical Trial Not Allowed) |
National Institutes of Health |
December 19th, 2023 |
HEAL Initiative: Limited Competition: Data Coordinating Center for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (U24 Clinical Trial Not Allowed) |
National Institutes of Health |